Podlipnik, S.; Martin, B.J.; Morgan-Linnell, S.K.; Bailey, C.N.; Siegel, J.J.; Petkov, V.I.; Puig, S.
The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma. Cancers 2024, 16, 287.
https://doi.org/10.3390/cancers16020287
AMA Style
Podlipnik S, Martin BJ, Morgan-Linnell SK, Bailey CN, Siegel JJ, Petkov VI, Puig S.
The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma. Cancers. 2024; 16(2):287.
https://doi.org/10.3390/cancers16020287
Chicago/Turabian Style
Podlipnik, Sebastian, Brian J. Martin, Sonia K. Morgan-Linnell, Christine N. Bailey, Jennifer J. Siegel, Valentina I. Petkov, and Susana Puig.
2024. "The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma" Cancers 16, no. 2: 287.
https://doi.org/10.3390/cancers16020287
APA Style
Podlipnik, S., Martin, B. J., Morgan-Linnell, S. K., Bailey, C. N., Siegel, J. J., Petkov, V. I., & Puig, S.
(2024). The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma. Cancers, 16(2), 287.
https://doi.org/10.3390/cancers16020287
